Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Becton, Dickinson and Company’s revenue for fiscal 2025 (year ended September 2025) was $21.8 billion, up 8.24% from fiscal 2024.

Revenue
−9.55%
EPS
−31.5%
Free cash flow
−31.6%
Total debt
−22.9%

Quarter to June 2026, against a year earlier

212.28 1.27 −0.59%
Market cap
$58.2B
P/E
64.1×
Fwd P/E
39.2×
Dividend yield
1.87%
F-score
7/9
Altman Z
1.85
Beneish M
−2.64
Dividend safety
67/100

Becton, Dickinson and Company (BDX) Total debt

Alert me on Total debt

Becton, Dickinson and Company's total debt at the end of fiscal 2025 was $17.6B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $13.5B. Over the past ten years it has ranged from $10.6B (fiscal 2016) to $18.9B (fiscal 2018); the current reading is higher than 64% of that period. Becton, Dickinson and Company ranks 1st of 50 Medical Instruments & Supplies companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $17.6B (1.78%)
FY2024 $17.9B 21.73%
FY2023 $14.7B 6.14%
FY2022 $13.9B (18.84%)
FY2021 $17.1B (0.66%)
FY2020 $17.2B (4.74%)
FY2019 $18.1B (4.30%)
FY2018 $18.9B 1.22%
FY2017 $18.7B 76.94%
FY2016 $10.6B (7.21%)

Quarterly newest first

Period Total debt Change
Jun 2026 $13.5B (8.13%)
Mar 2026 $14.7B (13.06%)
Dec 2025 $16.9B (4.00%)
Sep 2025 $17.6B 0.51%
42 more quarters

Against its own ten years

Low $10.6B High $18.9B
Ten-year median $17.2B
Current reading's percentile 64

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on BDX